Opioid prescribing in the United States before and after the centers for disease control and prevention's 2016 opioid guideline

Annals of Internal Medicine

Volumn 169, Issue 6, 2018, Pages 367-375

  Bohnert, Amy S B ^b   Guy, Gery P ^a   Losby, Jan L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; MORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT;

ARTICLE; DRUG MEGADOSE; DRUG USE; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNITED STATES; CHRONIC PAIN; CLINICAL PRACTICE; EPIDEMIOLOGY; PROTOCOL COMPLIANCE; PUBLIC HEALTH SERVICE; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; BENZODIAZEPINES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHRONIC PAIN; DRUG PRESCRIPTIONS; GUIDELINE ADHERENCE; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 85053524659     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M18-1243     Document Type: Article

References (37)

1. Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999-2016. National Center for Health Statistics data brief. Hyattsville, MD: National Center for Health Statistics; 2017.
2. Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010;59:705-9. [PMID: 20559200]
3. Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314:1468-78. [PMID: 26461997] doi:10.1001/jama.2015.11859
4. Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry. 2011;72:589-92. [PMID: 21536000] doi:10.4088/JCP.10com06560
5. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-21. [PMID: 21467284] doi:10.1001/jama.2011.370
6. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613-20. [PMID: 19066381] doi:10.1001 /jama.2008.802
7. Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199-207. [PMID: 14725960]
8. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686-91. [PMID: 21482846] doi: 10.1001/archinternmed.2011.117
9. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85-92. [PMID: 20083827] doi:10.7326/0003-4819-152-2-201001190-00006
10. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geri-atr Soc. 2015;63:2227-46. [PMID: 26446832] doi:10.1111/jgs.13702
11. Lin LA, Bohnert ASB, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain. 2017;158:833-9. [PMID: 28240996] doi:10.1097/j.pain .0000000000000837
12. Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177:611-2. [PMID: 28288245] doi:10 .1001/jamainternmed.2017.0147
13. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-65. [PMID: 10535437]
14. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993; 342:1317-22. [PMID: 7901634]
15. Audet AM, Greenfield S, Field M. Medical practice guidelines: current activities and future directions. Ann Intern Med. 1990;113: 709-14. [PMID: 2221652]
16. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315: 1624-45. [PMID: 26977696] doi:10.1001/jama.2016.1464
17. Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38-47. [PMID: 24217469] doi:10.7326/0003-4819-160-1-201401070-00732
18. Centers for Disease Control and Prevention. Guideline resources. Updated 31 August 2017. Accessed at www.cdc.gov/drugoverdose/prescribing/resources.html on 28 June 2018.
19. Centers for Disease Control and Prevention. Overdose prevention. Updated 31 August 2017. Accessed at www.cdc.gov/drugoverdose/prevention/index.html on 28 June 2018.
20. Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46:348-55. [PMID: 27283160] doi:10.1093/ije /dyw098
21. Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66:697-704. [PMID: 28683056] doi:10.15585/mmwr.mm6626a4
22. U.S. Census Bureau Population Division. Monthly Population Estimates for the United States: April 1, 2010 to December 1, 2017. Accessed at www.census.gov/data/tables/2017/demo/popest/nation-total.html on 18 June 2018.
23. National Center for Injury Prevention and Control. Data resources-oral MMEs. 2018. Accessed at www.cdc.gov/drugoverdose/resources/data.html on 28 June 2018.
24. French DD, Campbell R, Spehar A, Angaran DM. Benzodiazepines and injury: a risk adjusted model. Pharmacoepidemiol Drug Saf. 2005;14:17-24. [PMID: 15386711]
25. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299-309. [PMID: 12174032]
26. Linden A. Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata J. 2015;15:480-500.
27. Linden A. A comprehensive set of postestimation measures to enrich interrupted time-series analysis. Stata J. 2017;17:73-88.
28. Corcoran P, Griffin E, Arensman E, Fitzgerald AP, Perry IJ. Impact of the economic recession and subsequent austerity on suicide and self-harm in Ireland: an interrupted time series analysis. Int J Epidemiol. 2015;44:969-77. [PMID: 26082406] doi:10.1093/ije/dyv058
29. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698. [PMID: 26063215] doi:10.1136/bmj.h2698
30. Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175:608-15. [PMID: 25686208] doi:10.1001/jamainternmed.2014 .8071
31. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-30. [PMID: 19187889] doi:10.1016/j.jpain.2008.10.008
32. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline: management of opioid therapy for chronic pain. 2010. Accessed at www.va.gov/painmanagement/docs/cpg_opioidtherapy_fulltext.pdf on 28 June 2018.
33. Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34-47. [PMID: 25454406] doi:10.1016/j.drugalcdep.2014 .10.001
34. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med. 2003;163:1601-5. [PMID: 12860585]
35. Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, et al; FH02 Study Group. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014;16:442. [PMID: 25510853] doi:10 .1186/s13058-014-0442-6
36. Soumerai SB, Ceccarelli R, Koppel R. False dichotomies and health policy research designs: randomized trials are not always the answer. J Gen Intern Med. 2017;32:204-9. [PMID: 27757714] doi:10 .1007/s11606-016-3841-9
37. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378-82. [PMID: 26720857] doi:10 .15585/mmwr.mm6450a3